Abstract
Angiogenesis is stimulated by a variety of factors and underlies the pathology of many disease states, including cancer and blinding eye disease. It is often necessary to quantitate the angiogenic response to various stimuli and determine the efficacy of putative inhibitory agents. We describe a non-invasive method for measuring angiogenesis in a rabbit corneal model with precision and ease, regardless of geometrical irregularities in the vessel growth pattern.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aeillo, L.P., Avery, R.L., Arrigg, P.G., Keyt, B.A., Jampel, H.D., Shah, ST., Pasquale, L.R., Theime, H., Iwamoto, M.A., Park, J.E., Nguyen, H. V., Aiello, L.M., Ferrara, N., and King, G.L., 1994, Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders, New Eng. J. Med. 331: 1480–1487.
Antonelli-Orlidge, A., Saunders, K.B., Smith, S.R., and D’Amore, P.A., 1989, An activated form of TGF-beta is produced by co-cultures of endothelial cells and pericytes, Proc. Natl. Acad. Sci. USA 86: 4544.
BenEzra, D., Hemo, I., and Maftzir, G., 1990, In vivo angiogenic activity of interleukins, Arch. Ophthalmology 108: 573–576.
BenEzra, D., 1978, Neovasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants, American Journal of Pathology 86: 455–461.
Beutler, B. and Cerami, A., 1986, Cachectin and tumour necrosis factor as two sides of the same biological coin, Nature 320: 584.
Brooks, P., Clarke, R., and Cheresh, D., 1994, Requirement of vascular integrin alpha-v-beta-3 for angiogenesis, Science 264: 569.
Brooks, P., Montgomery, A., Rosenfeld, M., Reisfeld, R., Hu, T., Klier, G., and Cheresh, D., 1994, Integrin alpha-v-beta-3 antagonists promote tumor regression by inducing apoptosis of angiogenesis blood vessels, Cell 79: 1157–1104.
Chan, C.K., Kempin, S.J., Noble, S.K., and Palmer, G.A., 1993, The treatment of choroidal neovascular membranes by alpha interferon, Ophthal. 101: 289.
Cheresh, D.A., 1987, Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor, Proc. Natl. Acad. Sci. USA 84: 6471–6475.
Clark, R.A.F., Tonnesen, M.G., Gailit, J., and Cheresh, D., 1994, Integrin alpha-v-beta-3 on capillary sprouts promotes granulation tissue formation during porcine wound healing, J. Clin. Invest.
Conrad, T. J., Chandler, D. B., Corless, J. M., and Klintworth, G. K., 1994, In vivo measurement of corneal angiogenesis with video data acquisition and computerized image analysis, Laboratory Investigation 70: 426–433.
Cooper, C. A., Bergamini, M. V. W., and Leopold, I. H., 1980, Use of flurbiprofin to inhibit corneal neovascularization, Arch. Ophthalmology, 98: 1102–1105.
D’Amato, R. J., Loughnan, M. S., Flynn, E., and Folkman, J., 1994, Thalidomide is an inhibitor of angiogenesis. Proceedings of the National Academy of Sciences, USA. 91: 4082–4085.
D’Amore, P.A., 1994, Mechanisms of retinal and choroidal neovascularization, Invest. Ophthal. Vis. Sci. 35: 3974–3979.
Derynck, R., 1990, Transforming growth factor-alpha, Mol. Reprod. Dev. 27: 3.
Deutsch, T. A., and Hughes, F. W., 1979, Suppressive effects of indomethacin on thermally induced neovascularization of rabbit corneas, American Journal of Ophthalmology 87: 536–540.
Duffin, R. M., Weissman, B. A., Glasser, D. B., and Pettit, T. H., 1982, Flurbiprofin in the treatment of corneal neovascularization induced by contact lenses, American Journal of Pathology 93: 607–614.
Ezekowitz, R.A.B., Mulliken, J.B., and Folkman, J., 1992, Interferon alpha-2a therapy for life threatening hemangiomas of infancy, New Eng. J. Med. 326: 1456–1463.
Fett, J. W., Strydom, D. J., and Lobb, R. F., 1986, Isolation and characterization of angiogenesis in angiogenic protein from human carcinoma cells, Biochem. 24: 5480.
Fidler, F.J. and Ellis, L.M., 1994, The implications of angiogenesis for the biology of and therapy of cancer metastasis, Cell 79: 185–188.
Folkman, J., 1995, Angiogenesis in cancer, vascular, rheumatoid and other disease, Nature Medicine 1: 27–31.
Folkman, J., and Shing, Y., 1992, Angiogenesis, The Journal of Biological Chemistry 261: 10931–10934.
Folkman, J., 1992, The role of angiogenesis in tumor growth, Sem. Canc. Biol. 3: 65.
Friedlander, M., Shaffer, R., Kincaid, C, Brooks, P., and Cheresh, D., 1995, An antibody to the integrin αvβ3 inhibits ocular angiogenesis, Invest. Ophthalm. Vis. Sci. 36: S1047
Friedlander, M., Brooks, P., Shaffer, R., Kincaid, C, Varner, J., and Cheresh, D., 1995, Definition of two angiogenic pathways by distinct αv integrins, Science 270:1500–1502.
Frucht, J., and Zauberman, H., 1984, Topical indomethacin effect on neovascularization of the cornea and on prostaglandin E2 levels, British Journal of Ophthalmology 68: 656–659.
Glatt, H. J., and Klintworth, J. K., 1985, Quantitation of neovascularization in flat preparations of the cornea, Microvascular Research 31:104–109.
Hanneken, A., de Juan, E., Cutty, O.A., Fox, O.M., Schiffer, S., and Hzelmerade, R., 1991, Altered distribution of basic fibroblast growth factor in diabetic retinopathy, Arch. Ophthal. 109: 1005–1011.
Hynes, R.O., 1992, Integrins: Versatility, modulation, and signaling in cell adhesion, Cell 69: 11–25.
Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C, Hagiwara, K., Usuki, K., Takaku, F., Risau, W., and Heldin, C.-H., 1989, Nature 338: 557.
Jensen, A. J., Hunt, T. K., Scheuenstuhl, H., and Banda, M. J., 1986, Effect of lactate, pyruvate, and pH on secretion of angiogenesis and mitogenesis factors by macrophages, Laboratory Investigation 54: 574–578.
Leavesley, P.I., Schwartz, M.A., Rosenfeld, M., and Cheresh, D.A., 1993, Integrin beta-1 and beta-3 mediated endothelial cell migration is triggered through distinct signaling mechanisms, J. Cell Biol. 121: 163–170.
Madigan, M. C, Penfold, P. L., Holden, B. A., and Billson, F. A., 1990, Ultrastructural features of contact lens-induced deep corneal neovascularization and associated stromal leukocytes, Cornea 9(2): 144–151.
Malhotra, R., Stenn, K. S., Fernandez, L. A., and Braverman, I. M., 1989, Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis, Laboratory Investigation 61: 162–165.
Miller, J.W., Adamis, A.P., Shima, D.T., D’Amore, P.A., Moulton, R.S., O’Reilly, M.S., Folkman, J., Dvorak, H.F., Brown, L.F., Berse, B., Yeo, T.-K., and Yeo, K.-T., 1994, Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model, Am. J. Pathol. 145: 574–584.
Perrara, N., Houck, K., Jakeman, L., and Leung, D. W., 1992, Molecular and biological properties of neovascular endothelial growth factor family of proteins, Endocrin Dev. 13: 18–92.
Poliner, L.S., Tornambe, P.E., Michelson, P.E., and Heitzmann, J.G., 1993, Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration, Ophthal. 100: 1417.
Polverini, P. J., Cotran, R. S., Gimbrone, M. AS., and Unanue, E. R.,1977, Activated macrophages induce vascular proliferation, Nature 269: 804–806.
Proia, A. D., Chandler, D. B., Haynes, W. L., Smith, C. F., Suvarnamani, C, Erkel, F. H., and Klintworth, G. K., 1988, Quantitation of corneal neovascularization using computerized image analysis, Laboratory Investigation 58: 473–479.
Rastinejad, F., Polverri, P.J., and Bouck, N.P., 1989, Regulation of the activity of a new inhibitor of angiogenesis, Cell 56: 345–355.
Ruben, M., 1981, Corneal vascularization, International Ophthalmology Clinics 21: 27–38.
Shing, Y., Folkman, J., Sullivan, R., Butterfield, C, Murray, J. and Kagsburn, 1984, Heparin affinity: Purification of a tumor derived capillary endothelial cell growth factor, Science 223: 1296.
Sholley, M. M., Ferguson, G. P., Seibel, H. R., Hugo, R., Montour, J. L., and Wilson, J. D., 1984, Vascular sprouting can occur without proliferation of endothelial cells, Laboratory Investigation 51: 624–634.
White, C.W., Sondheimer, H.M., and Crouch, E.C., 1987, Treatment of pulmonary hemangiomatosis with recombinant interferon-alpha-2a, N. Eng. J. Med. 320: 1197.
Ziehe, M., Alessandri, G., and Gullino, P.M., 1989, Gangliosides promote the angiogenic response, Laboratory Investigation 61: 629–634.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Shaffer, R.W., Friedlander, M. (1996). A Method for the in Vivo Quantitation of Angiogenesis in the Rabbit Corneal Model. In: Maragoudakis, M.E. (eds) Molecular, Cellular, and Clinical Aspects of Angiogenesis. NATO ASI Series, vol 285. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0389-3_22
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0389-3_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8030-6
Online ISBN: 978-1-4613-0389-3
eBook Packages: Springer Book Archive